Glucagon-like peptide 1 (GLP-1) is a glucose-dependent insulin secretagogue and is established in the therapy of obesity with or without type 2 diabetes (4). The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.